The loss‐of‐function rs72613567:TA in hydroxysteroid 17‐beta dehydrogenase 13 (HSD17B13) was recently found to protect against the development and progression of both alcoholic and nonalcoholic chronic liver disease, while showing no association with simple steatosis.120, 121, 122. Here, HSD17B13 is linked to metabolic dysfunction-associated steatotic liver disease.